July 7, 2021 First patient enrolled in global multi-center randomized controlled trial with 564 patients at 15 sites comparing the impact of the Direct to Angio Suite workflow (diagnosis and treatment in the angio suite) to the conventional workflow (diagnosis in the CT or MRI suite followed by treatment in […]
Neuro
Sensome Receives FDA “Breakthrough Device Designation” for its AI-powered Stroke Guidewire
PARIS–(BUSINESS WIRE)–Sensome, the company pioneering the connected medical device revolution with the world’s smallest biological tissue sensor, announced today that it has been granted a Breakthrough Device designation by the Center of Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) for its Clotild® Smart Guidewire System designed […]
RapidAI Announces New Continuing Education Credits
Leader in Cerebrovascular and Vascular Imaging Expands Clinical Learning and Development Offerings through Rapid U Program SAN MATEO, Calif., June 8, 2021 /PRNewswire/ — RapidAI, the leader in clinical learning and development for stroke, aneurysm, and other cerebrovascular and vascular conditions, today announced the availability of Continuing Education (CE) and Continuing Medical Education […]
ABBOTT RECEIVES EUROPEAN AND CANADIAN APPROVAL FOR AMPLATZER™ STEERABLE DELIVERY SHEATH TO OPTIMIZE LEFT ATRIAL APPENDAGE CLOSURE PROCEDURES FOR PEOPLE AT RISK OF STROKE
– First-of-its-kind steerable delivery system designed for left atrial appendage (LAA) occluder to seal the LAA in people who are at increased risk of stroke due to atrial fibrillation – New delivery system works with Abbott’s leading Amplatzer Amulet™ LAA Occluder device to enable better access to the LAA and […]
Synchron Secures $40M in Series B led by Khosla Ventures to Launch U.S. Clinical Trials of Minimally Invasive Brain Computer Interface
Synchron’s flagship StentrodeTM endovascular implant does not require open brain surgery and has obtained FDA Breakthrough Device Designation for the treatment of paralysis The New York based company is already conducting human trials in Australia and is expected to commence a U.S. clinical trial in 2021 NEW YORK–(BUSINESS WIRE)–Synchron, a brain […]
IRRAS Announces Notified Body Transition from GMED to DEKRA, a Global Leader in Inspection and Certifications
STOCKHOLM, May 11, 2021 /PRNewswire/ — IRRAS AB, a commercial-stage medical technology company with a comprehensive portfolio of innovative products for neurocritical care, announced today that the CE Mark certificates for its IRRAflow system and the company’s ISO13485:2016 certification have been transferred to a new notified body, DEKRA. After the successful completion of […]
Worldwide Leader in Cerebrovascular Imaging Unveils Expansion of First Comprehensive Stroke Analytics Solution
New RapidAI Insights Improves Hospitals’ Understanding of Their Stroke Businesses, as Well as Patient Workflow and Outcomes MENLO PARK, Calif.–(BUSINESS WIRE)–RapidAI, the leader in advanced cerebrovascular imaging, today announced the expansion of RapidAI Insights, a unique analytics solution that uses Rapid® scan, treatment, and outcome data to enable hospitals and […]
Perflow Medical Expands Product Portfolio with First Clinical Use of the Stream™17 Dynamic Neuro-Thrombectomy Net
Device further expands the range of blood vessels that can now be treated for ischemic stroke. NETANYA, Israel, April 29, 2021 /PRNewswire/ — Perflow Medical, a private, Israeli-based innovator for neurovascular treatments, today announced the first successful clinical use of the Stream™17 Dynamic Neuro-Thrombectomy Net, a lower profile device designed for more tortuous anatomy, […]
Medtronic Partners with Surgical Theater to Provide First Augmented Reality Platform for Use in Real-Time During Complex Cranial Procedures
SyncAR™ Technology Uniquely Integrates with StealthStation™ S8 Surgical Navigation System and Expands the Use of Augmented Reality Into Operating Rooms to Enhance Precision and Efficiency DUBLIN and LOS ANGELES, April 26, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, and Surgical Theater today announced a partnership to interface Surgical Theater’s SyncAR™ augmented reality (AR) […]
Cerus Endovascular Announces IDE Approval from the U.S. FDA to Conduct Clinical Study of the Contour Neurovascular System™
Patient Enrollment to Begin Within Three Months FREMONT, Calif. and OXFORD, United Kingdom, April 21, 2021 /PRNewswire/ — Cerus Endovascular Ltd., a privately held, commercial-stage medical device company, today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational Device Exemption (IDE) application to conduct a U.S. trial for the Contour […]



